QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, October 17, 2007, 27(42):11366-11375; doi:10.1523/JNEUROSCI.2326-07.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Sloane, J. A. Articles by Vartanian, T. K. Search for Related Content PubMed PubMed Citation Articles by Sloane, J. A. Articles by Vartanian, T. K.

 Previous Article  |  Next Article 

Cellular/Molecular
Myosin Va Controls Oligodendrocyte Morphogenesis and Myelination

Jacob A. Sloane and Timothy K. Vartanian

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, Massachusetts 02215

Correspondence should be addressed to Timothy K. Vartanian, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Room 836, 77 Louis Pasteur Avenue, Boston, MA 02215. Email: tvartani{at}caregroup.harvard.edu

A product of myosin Va mutations, Griscelli's syndrome type 1 (GS1) is characterized by several neurologic deficits including quadraparesis, mental retardation, and seizures. Although multiple studies have not clearly established a cause for the neurologic deficits linked with GS1, a few reports suggest that GS1 is associated with abnormal myelination, which could cause the neurologic deficits seen with GS1. In this report, we investigate whether myosin Va is critical to oligodendrocyte morphology and to myelination in vivo. We found that myosin Va-null mice exhibit significantly impaired myelination of the brain, optic nerve, and spinal cord. Oligodendrocytes express myosin Va and loss of myosin Va function resulted in significantly smaller lamellas and decreased process number, length, and branching of oligodendrocytes. Loss of myosin Va function also blocked distal localization of vesicle-associated membrane protein 2 (VAMP2), which is known to associate with myosin Va. When VAMP2 function was disrupted, oligodendrocytes exhibited similar morphologic deficits to what is seen with functional ablation of myosin Va. Our findings establish a role for both myosin Va and VAMP2 in oligodendrocyte function as it relates to myelination.

Key words: oligodendrocyte; myelin; myosin Va; VAMP2; synaptobrevin-2; Griscelli's syndrome

---

Received May 22, 2007; revised Aug. 13, 2007; accepted Aug. 15, 2007.

Correspondence should be addressed to Timothy K. Vartanian, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Room 836, 77 Louis Pasteur Avenue, Boston, MA 02215. Email: tvartani{at}caregroup.harvard.edu

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2007 27: i. [Full Text]  

This article has been cited by other articles:

				H. Wang, A. Tewari, S. Einheber, J. L. Salzer, and C. V. Melendez-Vasquez Myosin II has distinct functions in PNS and CNS myelin sheath formation J. Cell Biol., September 22, 2008; 182(6): 1171 - 1184. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help